<strong>Bull trout streamflow and temperature linear SCR model</strong> by Patti Wohner (16398345)

“…These extremes provided a unique opportunity to retrospectively compare bull trout survival and migration under potential climate change scenarios. …”

Effects of experimental warming and CO₂ addition on tide pools. by Cascade J. B. Sorte (223319)

Effects of TIIA on histological changes at 24 h after SCI. by Xin Yin (149454)

“…The histological score was accessed in a blinded manner (E). MPO activity in tissues was significantly increased at 24 h in the SCI group compared with the sham and sham/TIIA groups and was decreased with the treatment of TIIA (F). …”

Proinflammatory cytokines in the liver. by Hyunseong Kim (670519)

“…The values shown indicate the means ± S.E.M. *P<0.05 vs. APAP, **P<0.01 vs. APAP, ***P<0.001 vs. …”

The gene expression of Notch receptors and their downstream effectors in PH rats. by Lina Qiao (111668)

“…The mRNA level of HERP2 decreased at the first day and maintained a low level in the following days. (*, P<0.05 compared to control group, Data were normalized to GAPDH and expressed as means ± s.e.m.)…”

GATA elements control repression of cardiac troponin I promoter activity in skeletal muscle cells-7 by Raffaella Di Lisi (63653)

“…Values (means ± S.E.) are expressed as fold increase in normalized CAT activity over the promoterless construct. …”

Pyruvate reduces R/M hypoglycemia-induced cortical blood vessel loss. by Bo Young Choi (301014)

“…(B) Graph represents the % area of RECA-1 immunoreactivity in the parietal and perirhinal cortex. Data are means ± s.e.m., n=5-6 from each group, *<i>P</i><0.05.…”

FASN inhibitors induced cell death of MCL cells. by Pascal Gelebart (174443)

“…At 48 hours, the number of viable cells, as determined by using the trypan blue exclusion assay, decreased in a dose-dependent manner. Experiments were performed in triplicate and the means +/− standard deviations are shown. …”

Effect of 60 mM and 180 mM NaCl on the growth of six potato cultivars. by Rinse Jaarsma (393609)

“…Results are means of three replicates and expressed as percentages from the weight of control plants. …”

Effect of detachment procedures on B16F10-luc tumor cells. by Pierre Danhier (180165)

“…Trypsin treatment (C) or dissolving the coating of Cytodex 3 microbeads (F) result both in cell detachment while control cells (B and E) remain adherent. Data are expressed as means ± SEM.…”

Effect of intraperitoneally (IP) injected Wy-14643 on meal pattern. by Elnaz Karimian Azari (459618)

“…Wy-14643 increased the latency of the first meal (<b>A</b>) and decreased the second meal size (<b>E</b>), but did not significantly affect first meal size and duration (<b>B</b>, <b>C</b>), intermeal interval (<b>D</b>) and second meal duration (<b>F</b>). …”

GATA elements control repression of cardiac troponin I promoter activity in skeletal muscle cells-1 by Raffaella Di Lisi (63653)

“…Values (means ± S.E.) are expressed as fold increase in normalized CAT activity over the promoterless construct. …”

Reconstructing the cochlear spectrograms from firing rates. by Florian Blättler (201240)

“…This fraction decreases to 0.1% at about . (E) The reconstruction errors averaged over different stimulus ensembles are monotonic functions of the firing threshold. …”

Increased circulating TSH activates protein kinase A (PKA) via the TSH receptor and the second-messenger cAMP in thyroid follicular cells by Christine M. Glatt (60496)

Quantitative morphometric and immunohistochemical analysis of neointima formation and RanGAP1 expression in the rat carotid artery injury model. by Marc Vorpahl (591604)

“…RanGAP1 expression in the media was the highest at the initiation of cellular proliferation and decreased to barely detectable levels at the completion of neointima formation (C). 3 days post injury, almost all cells in the neointima stained positive for RanGAP1 and subsequently, levels decrementally decreased at later time points, e.g. at day 7 and day 14 (D). …”

Table_8_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.XLSX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_1_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_6_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_10_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_2_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.XLSX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”